Funds holding ADIAL PHARMACEUTICALS INC
ISIN US00688A3041 · United States
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 15.7K $
- Share of capital
- 0.2 % of 2.6M shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 5,277 | 13.4K $ | 0.20 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 366 | 926 $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 361 | 646.2 $ | 0.01 % | as of Mar 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 310 | 784.3 $ | 0.01 % | as of Feb 28, 2026 ↗ |
Institutional managers
12 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 24,249 | 43.4K $ | as of Mar 31, 2026 |
| Manchester Capital Management LLC | 1,923 | 3.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,356 | 2.4K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,110 | 2K $ | as of Mar 31, 2026 |
| UBS Group AG | 542 | 970 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 50 | 90 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 47 | 84 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 15 | 27 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 6 | 11 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 4 | 7 $ | as of Mar 31, 2026 |
| HARBOUR INVESTMENTS, INC. | 3 | 5 $ | as of Mar 31, 2026 |
| Abound Wealth Management | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of ADIAL PHARMACEUTICALS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Coastlands Capital LP and 4 others | 9.98 % | 262,167 | as of Jun 17, 2026 · SCHEDULE 13G |
| Armistice Capital, LLC and 1 other | 4.99 % | 274,139 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ADIAL PHARMACEUTICALS INC". https://titelia.com/en/stocks/adial-pharmaceuticals-inc-US00688A3041